Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Eftimov, F.

Refine Results

Resource Type

Availability

Creation Date

Author

Show more

Language

Search results

  • RSS Feed
(1 - 17 of 17)
CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barre syndrome
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Comprehensive overview of autoantibody isotype and subclass distribution
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Predicting outcome in Guillain-Barre syndrome
Second intravenous immunoglobulin dose in patients with Guillain-Barre syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP PATH extension study
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial